Comments
Loading...

CVS Health

CVSNYSE
$61.17
1.111.84%
Last update: 1:34 PM
15 minutes delayed
The dividend Ex-Date is in 5 days
Consensus Rating1
Buy
Highest Price Target1
$143.00
Lowest Price Target1
$58.00
Consensus Price Target1
$90.14

want to know what
the Bulls & Bears Say?

CVS Health (NYSE:CVS) Stock, Analyst Ratings, Price Targets, Forecasts

CVS Health Corp has a consensus price target of $90.14 based on the ratings of 36 analysts. The high is $143 issued by Jefferies on February 9, 2023. The low is $58 issued by Cantor Fitzgerald on June 12, 2024. The 3 most-recent analyst ratings were released by Cantor Fitzgerald, JP Morgan, and Baird on June 12, 2024, May 30, 2024, and May 30, 2024, respectively. With an average price target of $68.33 between Cantor Fitzgerald, JP Morgan, and Baird, there's an implied 11.71% upside for CVS Health Corp from these most-recent analyst ratings.

Analyst Trends and Forecast
3
Feb
1
1
Mar
2
1
Apr
1
6
May
1
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.7
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Cantor Fitzgerald
JP Morgan
Baird
Argus Research
Wells Fargo

1calculated from analyst ratings

Analyst Ratings for CVS Health

Buy NowGet Alert
06/12/2024Buy Now-5.18%Cantor Fitzgerald
Sarah James
$58 → $58ReiteratesNeutral → NeutralGet Alert
05/30/2024Buy Now40.6%JP Morgan
Lisa Gill
$101 → $86MaintainsOverweightGet Alert
05/30/2024Buy Now-0.27%Baird
Michael Ha
→ $61Initiates → NeutralGet Alert
05/08/2024Buy Now30.79%Argus Research
Chris Graja
$100 → $80MaintainsBuyGet Alert
05/07/2024Buy Now-1.91%Wells Fargo
Stephen Baxter
$76 → $60MaintainsEqual-WeightGet Alert
05/07/2024Buy Now-3.54%TD Cowen
Charles Ryhee
$99 → $59DowngradeBuy → HoldGet Alert
05/02/2024Buy Now25.88%B of A Securities
Michael Cherny
$95 → $77MaintainsBuyGet Alert
05/02/2024Buy Now20.98%Goldman Sachs
Nathan Rice
$85 → $74MaintainsBuyGet Alert
05/02/2024Buy Now3%Barclays
Andrew Mok
$78 → $63MaintainsEqual-WeightGet Alert
05/02/2024Buy Now-1.91%UBS
Kevin Caliendo
$85 → $60DowngradeBuy → NeutralGet Alert
05/02/2024Buy Now7.9%Truist Securities
David Macdonald
$90 → $66ReiteratesBuy → BuyGet Alert
05/02/2024Buy Now17.71%Mizuho
Ann Hynes
$86 → $72MaintainsBuyGet Alert
05/01/2024Buy Now-1.91%Leerink Partners
Michael Cherny
→ $60DowngradeOutperform → Market PerformGet Alert
05/01/2024Buy Now-5.18%Cantor Fitzgerald
Sarah James
$87 → $58DowngradeOverweight → NeutralGet Alert
04/10/2024Buy Now42.23%Cantor Fitzgerald
Sarah James
→ $87ReiteratesOverweight → OverweightGet Alert
04/08/2024Buy Now24.25%Wells Fargo
Stephen Baxter
$83 → $76MaintainsEqual-WeightGet Alert
04/04/2024Buy Now42.23%Cantor Fitzgerald
Sarah James
→ $87ReiteratesOverweight → OverweightGet Alert
03/15/2024Buy Now53.68%Piper Sandler
Jessica Tassan
$93 → $94MaintainsOverweightGet Alert
03/06/2024Buy Now27.52%Barclays
Andrew Mok
→ $78Initiates → Equal-WeightGet Alert
02/26/2024Buy Now43.87%Leerink Partners
Michael Cherny
→ $88Initiates → OutperformGet Alert
02/08/2024Buy Now42.23%Cantor Fitzgerald
Sarah James
→ $87ReiteratesOverweight → OverweightGet Alert
02/08/2024Buy Now37.33%RBC Capital
Ben Hendrix
$86 → $84MaintainsOutperformGet Alert
12/22/2023Buy Now53.68%HSBC
Daniela Bretthauer
→ $94Initiates → BuyGet Alert
12/11/2023Buy Now61.85%TD Cowen
Charles Ryhee
$102 → $99MaintainsOutperformGet Alert
11/21/2023Buy Now42.23%Cantor Fitzgerald
Sarah James
→ $87ReiteratesOverweight → OverweightGet Alert
11/02/2023Buy Now40.6%Mizuho
Ann Hynes
$88 → $86MaintainsBuyGet Alert
11/02/2023Buy Now40.6%RBC Capital
Ben Hendrix
$91 → $86MaintainsOutperformGet Alert
11/02/2023Buy Now63.48%Morgan Stanley
Erin Wright
$110 → $100MaintainsOverweightGet Alert
09/19/2023Buy Now35.69%Evercore ISI Group
Elizabeth Anderson
$81 → $83UpgradeIn-Line → OutperformGet Alert
09/14/2023Buy Now42.23%Cantor Fitzgerald
Sarah James
→ $87ReiteratesOverweight → OverweightGet Alert
09/12/2023Buy Now30.79%Wolfe Research
Justin Lake
→ $80UpgradePeer Perform → OutperformGet Alert
09/01/2023Buy Now34.06%Piper Sandler
Jessica Tassan
$85 → $82MaintainsOverweightGet Alert
08/18/2023Buy Now48.77%RBC Capital
Ben Hendrix
→ $91ReiteratesOutperform → OutperformGet Alert
08/18/2023Buy NowEdward Jones
Ashtyn Evans
DowngradeBuy → HoldGet Alert
08/04/2023Buy Now38.96%Raymond James
John Ransom
$90 → $85MaintainsOutperformGet Alert
08/03/2023Buy Now60.21%Truist Securities
David Macdonald
$103 → $98MaintainsBuyGet Alert
08/03/2023Buy Now79.83%Morgan Stanley
Erin Wright
$120 → $110MaintainsOverweightGet Alert
08/03/2023Buy Now48.77%RBC Capital
Ben Hendrix
$102 → $91MaintainsOutperformGet Alert
08/03/2023Buy Now40.6%Barclays
Steve Valiquette
$89 → $86MaintainsOverweightGet Alert
07/12/2023Buy Now45.5%Barclays
Steve Valiquette
$90 → $89MaintainsOverweightGet Alert
07/11/2023Buy Now43.87%Mizuho
Ann Hynes
$120 → $88MaintainsBuyGet Alert
07/07/2023Buy Now73.29%JP Morgan
Lisa Gill
$114 → $106MaintainsOverweightGet Alert
06/20/2023Buy Now68.39%Truist Securities
David Macdonald
$109 → $103MaintainsBuyGet Alert
05/30/2023Buy Now86.37%JP Morgan
Lisa Gill
$125 → $114MaintainsOverweightGet Alert
05/26/2023Buy Now38.96%Piper Sandler
Jessica Tassan
→ $85Initiates → OverweightGet Alert
05/09/2023Buy Now66.75%RBC Capital
Ben Hendrix
→ $102Reiterates → OutperformGet Alert
05/08/2023Buy Now24.25%Wells Fargo
Stephen Baxter
$95 → $76MaintainsEqual-WeightGet Alert
05/08/2023Buy Now56.95%Credit Suisse
A.J. Rice
$125 → $96MaintainsOutperformGet Alert
05/08/2023Buy Now47.14%Raymond James
John Ransom
$110 → $90MaintainsOutperformGet Alert
05/05/2023Buy Now43.87%Goldman Sachs
Nathan Rice
$100 → $88MaintainsBuyGet Alert
05/04/2023Buy Now43.87%Goldman Sachs
Nathan Rich
$100 → $88MaintainsBuyGet Alert
05/04/2023Buy Now47.14%Barclays
Steve Valiquette
$100 → $90MaintainsOverweightGet Alert
05/02/2023Buy Now53.68%UBS
Kevin Caliendo
$102 → $94MaintainsBuyGet Alert
05/02/2023Buy Now52.04%Bernstein
Lance Wilkes
$107 → $93MaintainsMarket PerformGet Alert
04/21/2023Buy Now42.23%Cantor Fitzgerald
Sarah James
→ $87Initiates → OverweightGet Alert
04/18/2023Buy Now81.47%TD Cowen
Charles Ryhee
$118 → $111MaintainsOutperformGet Alert
03/31/2023Buy Now70.02%B of A Securities
Michael Cherny
$111 → $104MaintainsBuyGet Alert
03/30/2023Buy Now63.48%Barclays
Steven Valiquette
$110 → $100MaintainsOverweightGet Alert
02/09/2023Buy Now133.78%Jefferies
Brian Tanquilut
$130 → $143MaintainsBuyGet Alert
02/09/2023Buy Now88.01%RBC Capital
Ben Hendrix
→ $115Reiterates → OutperformGet Alert
02/09/2023Buy Now79.83%Raymond James
John Ransom
$115 → $110MaintainsOutperformGet Alert
02/09/2023Buy Now79.83%Barclays
Steve Valiquette
$118 → $110MaintainsOverweightGet Alert
01/13/2023Buy Now96.18%Morgan Stanley
Erin Wright
$119 → $120MaintainsOverweightGet Alert
01/03/2023Buy Now65.12%Wells Fargo
Stephen Baxter
$106 → $101MaintainsEqual-WeightGet Alert
01/03/2023Buy Now63.48%Evercore ISI Group
Elizabeth Anderson
$120 → $100DowngradeOutperform → In-LineGet Alert
11/23/2022Buy Now94.55%Morgan Stanley
Erin Wright
$124 → $119Assumes → OverweightGet Alert
11/21/2022Buy Now104.36%Credit Suisse
A.J. Rice
$117 → $125MaintainsOutperformGet Alert
11/08/2022Buy Now73.29%Wells Fargo
Stephen Baxter
$111 → $106MaintainsEqual-WeightGet Alert
11/07/2022Buy Now88.01%RBC Capital
Ben Hendrix
$119 → $115MaintainsOutperformGet Alert
11/07/2022Buy Now88.01%Raymond James
John Ransom
$120 → $115MaintainsOutperformGet Alert
11/03/2022Buy Now104.36%JP Morgan
Lisa Gill
$130 → $125MaintainsOverweightGet Alert
11/03/2022Buy Now84.74%Goldman Sachs
Nathan Rich
$128 → $113MaintainsBuyGet Alert
10/20/2022Buy Now92.91%B of A Securities
Michael Cherny
$122 → $118MaintainsBuyGet Alert
10/11/2022Buy Now102.72%Morgan Stanley
Ricky Goldwasser
$127 → $124MaintainsOverweightGet Alert
09/07/2022Buy Now104.36%Evercore ISI Group
Elizabeth Anderson
$120 → $125MaintainsOutperformGet Alert
08/15/2022Buy Now96.18%Mizuho
Ann Hynes
$115 → $120MaintainsBuyGet Alert
08/08/2022Buy Now91.28%Credit Suisse
Jonathan Yong
$113 → $117MaintainsOutperformGet Alert
08/04/2022Buy Now107.63%UBS
Kevin Caliendo
$118 → $127MaintainsBuyGet Alert
06/17/2022Buy Now96.18%Loop Capital
Joseph France
→ $120Initiates → BuyGet Alert
05/27/2022Buy Now83.1%Bernstein
Lance Wilkes
→ $112DowngradeOutperform → Market PerformGet Alert
05/05/2022Buy Now84.74%Deutsche Bank
George Hill
$110 → $113MaintainsHoldGet Alert
05/05/2022Buy Now107.63%Morgan Stanley
Ricky Goldwasser
$125 → $127MaintainsOverweightGet Alert
03/29/2022Buy Now79.83%Deutsche Bank
George Hill
→ $110DowngradeBuy → HoldGet Alert
02/14/2022Buy Now96.18%Raymond James
John Ransom
$115 → $120DowngradeStrong Buy → OutperformGet Alert
12/23/2021Buy Now99.45%Tigress Financial
Ivan Feinseth
$108 → $122MaintainsBuyGet Alert
12/20/2021Buy Now88.01%Mizuho
Ann Hynes
MaintainsBuyGet Alert
12/14/2021Buy Now97.82%Goldman Sachs
Nathan Rich
Initiates → BuyGet Alert
12/13/2021Buy Now104.36%Morgan Stanley
Craig Hettenbach
MaintainsOverweightGet Alert
12/13/2021Buy Now74.93%Wells Fargo
Stephen Baxter
MaintainsEqual-WeightGet Alert
12/10/2021Buy Now79.83%Mizuho
Ann Hynes
MaintainsBuyGet Alert
12/10/2021Buy Now96.18%Credit Suisse
Jonathan Yong
MaintainsOutperformGet Alert
12/06/2021Buy Now88.01%Morgan StanleyMaintainsOverweightGet Alert
12/01/2021Buy Now79.83%Seaport Global
Joseph France
Initiates → BuyGet Alert
11/10/2021Buy Now71.66%Mizuho
Ann Hynes
MaintainsBuyGet Alert
11/05/2021Buy Now74.93%Credit Suisse
A.J. Rice
MaintainsOutperformGet Alert
11/04/2021Buy Now74.93%RBC Capital
Frank Morgan
MaintainsOutperformGet Alert
11/04/2021Buy Now79.83%Barclays
Steve Valiquette
MaintainsOverweightGet Alert
11/04/2021Buy Now88.01%Raymond James
John Ransom
MaintainsStrong BuyGet Alert
08/31/2021Buy Now86.37%Morgan Stanley
Craig Hettenbach
MaintainsOverweightGet Alert

FAQ

Q

What is the target price for CVS Health (CVS) stock?

A

The latest price target for CVS Health (NYSE:CVS) was reported by Cantor Fitzgerald on June 12, 2024. The analyst firm set a price target for $58.00 expecting CVS to fall to within 12 months (a possible -5.18% downside). 39 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for CVS Health (CVS)?

A

The latest analyst rating for CVS Health (NYSE:CVS) was provided by Cantor Fitzgerald, and CVS Health reiterated their neutral rating.

Q

When was the last upgrade for CVS Health (CVS)?

A

The last upgrade for CVS Health Corp happened on September 19, 2023 when Evercore ISI Group raised their price target to $83. Evercore ISI Group previously had an in-line for CVS Health Corp.

Q

When was the last downgrade for CVS Health (CVS)?

A

The last downgrade for CVS Health Corp happened on May 7, 2024 when TD Cowen changed their price target from $99 to $59 for CVS Health Corp.

Q

When is the next analyst rating going to be posted or updated for CVS Health (CVS)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CVS Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CVS Health was filed on June 12, 2024 so you should expect the next rating to be made available sometime around June 12, 2025.

Q

Is the Analyst Rating CVS Health (CVS) correct?

A

While ratings are subjective and will change, the latest CVS Health (CVS) rating was a reiterated with a price target of $58.00 to $58.00. The current price CVS Health (CVS) is trading at is $61.17, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch